2011Chin J PsychiatryRequires access

Notch1 signaling pathway involves in hippocampal neurogenesis on depressive-like rat models

Yuxiu Sui, Zhijun Zhang, Yijing Guo

Open publisher page 1 citations

Abstract

Objective To investigate whether the effect of fluoxetine on hippocampal neurogenesis involves Notch1 signaling after chronic stress. Methods Sixty-eight male Sprague-Dawley rats were divided into control group, control + fluoxetine group, depression model group and depression model + fluoxetine group. Chronic unpredictable mild stress (CUMS) was used to make up depression animal model. The function of Notch1 signaling was measured by real-time PCR and western blotting. Simultaneously,hippocampal neurogenesis was monitored by assessing cell proliferation and survival. Results (1) Before starting CUMS protocol, the animals exhibited equivalent weight, sucrose preference, number of squares crossed, number of rearing, and immobility time in behavioral test. Twenty-eight days after CUMS protocol,these parameters were significantly difference in rats exposed to CUMS compared with the controls (sucrose preference, number of squares crossed, number of grooming and rearing, and immobility time, P<0. 01).Administration of fluoxetine was shown to dramatically improve the depression behavior (P<0. 01) .(2) The cell proliferation [(3047. 61 ± 158. 29) vs. (1900. 33 ± 104. 10)] and survive [(2704. 21 ±154. 31) vs. (1845.33 ± 126.88)] were increased after fluoxetine administration in rats with depression (P<0. 01). (3) Fluoxetine increased mRNA expressions of Notch1 signaling components [NICD mRNA (0. 23 ±0. 01) vs. (0. 10 ±0.01), Hes1 mRNA (0. 56 ±0.04) vs. (0. 28 ±0.02), Hes5 mRNA (0. 24 ±0.02) vs. (0.10 ±0.02), Jag1 mRNA (0.82 ±0.06) vs. (0.56 ±0.03)] in the rat hippocampus compared with the CUMS group (P<0. 01 or P<0. 001). Fluoxetine enhanced protein levels of Notch1 signaling components [NICD(1.99 ±0.07) vs. (0.53 ±0.10), Hes5(0. 64 ±0. 04) vs. (0.37 ±0.09),Jag1 (2. 34 ± 0. 13) vs. (0. 68 ± 0. 17)] in the rat hippocampus compared with the CUMS group (P <0.01). Conclusion The up-regulation of the Notch1 pathway with chronic fluoxetine administration might partly contribute to increased neurogenesis in the rat hippocampus with depression. Key words: Fluoxetine;  Depression;  Signal transduction;  Nerve regeneration;  Chronic unpredictable mild stress

About this research paper

What this paper is about

Objective To investigate whether the effect of fluoxetine on hippocampal neurogenesis involves Notch1 signaling after chronic stress. Methods Sixty-eight male Sprague-Dawley rats were divided into control group, control + fluoxetine group, depression model group and depression model + fluoxetine group. Chronic unpredictable mild stress (CUMS) was used to make up depression animal model. The function of Notch1 signaling was measured by real-time PCR and western blotting. Simultaneously,hippocampal neurogenesis was monitored by assessing cell proliferation and survival. Results (1) Before starting CUMS protocol, the animals exhibited equivalent weight, sucrose preference, number of squares crossed, number of rearing, and immobility time in behavioral test. Twenty-eight days after CUMS protocol,these parameters were significantly difference in rats exposed to CUMS compared with the controls (sucrose preference, number of squares crossed, number of grooming and rearing, and immobility time, P<0. 01).Administration of fluoxetine was shown to dramatically improve the depression behavior (P<0. 01) .(2) The cell proliferation [(3047. 61 ± 158. 29) vs. (1900. 33 ± 104. 10)] and survive [(2704. 21 ±154. 31) vs. (1845.33 ± 126.88)] were increased after fluoxetine administration in rats with depression (P<0. 01). (3) Fluoxetine increased mRNA expressions of Notch1 signaling components [NICD mRNA (0. 23 ±0. 01) vs. (0. 10 ±0.01), Hes1 mRNA (0. 56 ±0.04) vs. (0. 28 ±0.02), Hes5 mRNA (0. 24 ±0.02) vs. (0.10 ±0.02), Jag1 mRNA (0.82 ±0.06) vs. (0.56 ±0.03)] in the rat hippocampus compared with the CUMS group (P<0. 01 or P<0. 001). Fluoxetine enhanced protein levels of Notch1 signaling components [NICD(1.99 ±0.07) vs. (0.53 ±0.10), Hes5(0. 64 ±0. 04) vs. (0.37 ±0.09),Jag1 (2. 34 ± 0. 13) vs. (0. 68 ± 0. 17)] in the rat hippocampus compared with the CUMS group (P <0.01). Conclusion The up-regulation of the Notch1 pathway with chronic fluoxetine administration might partly contribute to increased neurogenesis in the rat hippocampus with depression. Key words: Fluoxetine;  Depression;  Signal transduction;  Nerve regeneration;  Chronic unpredictable mild stress

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate whether the effect of fluoxetine on hippocampal neurogenesis involves Notch1 signaling after chronic stress. Methods Sixty-eight male Sprague-Dawley rats were divided into control group, control + fluoxetine group, depression model group and depression model + fluoxetine group. Chronic unpredictable mild stress (CUMS) was used to make up depression animal model. The function of Notch1 signaling was measured by real-time PCR and western blotting. Simultaneously,hippocampal neurogenesis was monitored by assessing cell proliferation and survival. Results (1) Before starting CUMS protocol, the animals exhibited equivalent weight, sucrose preference, number of squares crossed, number of rearing, and immobility time in behavioral test. Twenty-eight days after CUMS protocol,these parameters were significantly difference in rats exposed to CUMS compared with the controls (sucrose preference, number of squares crossed, number of grooming and rearing, and immobility time, P<0. 01).Administration of fluoxetine was shown to dramatically improve the depression behavior (P<0. 01) .(2) The cell proliferation [(3047. 61 ± 158. 29) vs. (1900. 33 ± 104. 10)] and survive [(2704. 21 ±154. 31) vs. (1845.33 ± 126.88)] were increased after fluoxetine administration in rats with depression (P<0. 01). (3) Fluoxetine increased mRNA expressions of Notch1 signaling components [NICD mRNA (0. 23 ±0. 01) vs. (0. 10 ±0.01), Hes1 mRNA (0. 56 ±0.04) vs. (0. 28 ±0.02), Hes5 mRNA (0. 24 ±0.02) vs. (0.10 ±0.02), Jag1 mRNA (0.82 ±0.06) vs. (0.56 ±0.03)] in the rat hippocampus compared with the CUMS group (P<0. 01 or P<0. 001). Fluoxetine enhanced protein levels of Notch1 signaling components [NICD(1.99 ±0.07) vs. (0.53 ±0.10), Hes5(0. 64 ±0. 04) vs. (0.37 ±0.09),Jag1 (2. 34 ± 0. 13) vs. (0. 68 ± 0. 17)] in the rat hippocampus compared with the CUMS group (P <0.01). Conclusion The up-regulation of the Notch1 pathway with chronic fluoxetine administration might partly contribute to increased neurogenesis in the rat hippocampus with depression. Key words: Fluoxetine;  Depression;  Signal transduction;  Nerve regeneration;  Chronic unpredictable mild stress

Key concepts: Fluoxetine, Hippocampal formation, Neurogenesis, Endocrinology, Hippocampus, Internal medicine, Medicine, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Notch1 signaling pathway involves in hippocampal neurogenesis on depressive-like rat models — Research Paper | ScholarLens